ARX:ASX
Aroa Biosurgery Ltd
A$0.48
arrow_downward
-1.02%(-0.0050) 1D
Nov 20, 4:10:08 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.50
High
A$0.50
Low
A$0.48
Mkt. cap
166.12M
Avg. vol.
259.42K
Volume
192.34K
P/E ratio
46.19
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.50
High
A$0.50
Low
A$0.48
Mkt. cap
166.12M
Avg. vol.
259.42K
Volume
192.34K
P/E ratio
46.19
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
Reuters
·
28 minutes ago
SocGen sees S&P 500 ending 2027 at 8,500 on AI, earnings support
Bloomberg.com
·
29 minutes ago
S&P 500 Faces Technical Make-or-Break Moment Below 7,200 Line
Traders Union
·
1 hour ago
Mohamed A. El-Erian: S&P 500 may face longest losing streak since 2020 as 10-year Treasury yield falls
Barron's
·
1 hour ago
S&P 500 Futures Decline in Premarket Trading; Lennar, Louisiana-Pacific Lag
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd